MDxHealth (MDxHealth) Additional Paid-In Capital : $153.18 Mil(As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is MDxHealth Additional Paid-In Capital?

MDxHealth's quarterly additional paid-in capital stayed the same from Mar. 2023 ($153.18 Mil) to Jun. 2023 ($153.18 Mil) and stayed the same from Jun. 2023 ($153.18 Mil) to Sep. 2023 ($153.18 Mil).

MDxHealth's annual additional paid-in capital increased from Dec. 2020 ($136.35 Mil) to Dec. 2021 ($153.18 Mil) but then stayed the same from Dec. 2021 ($153.18 Mil) to Dec. 2022 ($153.18 Mil).

MDxHealth Additional Paid-In Capital Historical Data

The historical data trend for MDxHealth's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MDxHealth Additional Paid-In Capital Chart

MDxHealth Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

135.73

136.35

153.18

MDxHealth Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Additional Paid-In Capital	Get a 7-Day Free Trial															153.18	153.18	153.18	153.18	153.18

MDxHealth Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

MDxHealth Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of MDxHealth's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

MDxHealth (MDxHealth) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » MDxHealth SA (NAS:MDXH) » Definitions » Additional Paid-In Capital

Comparable Companies

BIOQ PSNL VNRX PRE ENZ PRPH ACRS BNR DRIO AWH TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

N/A

Address

Rue d’Abhooz, 31, Cap Business Center, Herstal, Liege, BEL, 4040

Website

https://www.mdxhealth.com

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.